Trending

Mundipharma

Mundipharma buys Spanish biosimilars firm Cinfa Biotech

Mundipharma buys Spanish biosimilars firm Cinfa Biotech

Mundipharma, a network of independent pharma companies, has bought Spanish biosimilars development company Cinfa Biotech. The deal will

X

Mundipharma buys Spanish biosimilars firm Cinfa Biotech

https://pharmaphorum.com/news/mundipharma-buys-spanish-biosimilars-firm-cinfa-biotech/

Mundipharma to market Herceptin biosimilar in key EU markets

Mundipharma to market Herceptin biosimilar in key EU markets

Mundipharma’s third biosimilar tie-up with Celltrion

X

Mundipharma to market Herceptin biosimilar in key EU markets

https://pharmaphorum.com/news/mundipharma-market-celltrion-cancer-biosimilar-key-eu-markets/

Mundipharma buys rights to CellAct cancer drug

Mundipharma buys rights to CellAct cancer drug

Drug will be progressed through phase 3 trials in biliary tract cancer.

X

Mundipharma buys rights to CellAct cancer drug

https://pharmaphorum.com/news/mundipharma-cellact/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com